Using Phylogeny Approach on Ethnobotanical Bioprospecting for Leading Antimalarial Plant-Based Drug Discovery

Desy Liana, Kanchana Rungsihirunrat

Abstract


Ethnobotanical-directed bioprospecting has made a significant contribution to modern drug discoveries. However, merely relying on this approach may spend more expenditure, time-consuming, and lead exhaustive laboratory testing due to the tremendous data of medicinal plants used and the occurrence of placebo effect during traditional medical treatment. Combining the phylogeny approach with ethnobotanical bioprospecting may become new prospective tools to lead the plant-based drug discovery, including antimalaria. This study aimed to map the ethnomedicinal plants used by various indigenous cultures to investigate the clustered pattern of its antimalarial properties for future bioprospecting. The Internal Transcribed Spacer (ITS) region sequences of selected 280 medicinal plants taxa obtained from NCBI (National Center for Biotechnology Information) were aligned by MUSCLE multiple sequences alignments. They were further analyzed using the Maximum Likelihood Phylogenetic Test by MEGA X software to construct the phylogenetic tree. Our research revealed that the medicinal plant taxa for malaria treatment was clumped in several families, including Apocynaceae, Euphorbiaceae, Rubiaceae, Rutaceae, Fabaceae were strongly clumped along with plants used for fever in the Asteraceae family. Interestingly, our finding showed that these plants were clumped in the sub-family of antimalarial producing species, the Asteroidea. Furthermore, the strongly clumping pattern was also shown in the tribe Heliantheae alliance of this sub-family. This finding supports the predictive power of phylogeny for future bioprospecting to select the candidate taxa to lead the drug discovery.


Keywords


Phylogeny; bioprospecting; ethnomedicinal plants; malaria; drug discovery.

Full Text:

PDF

References


S. B. McCreath and R. Delgoda, Pharmacognosy: Fundamentals, applications and strategies. Academic Press, 2017.

M. A. Aziz, A. H. Khan, M. Adnan, and I. Izatullah, “Traditional uses of medicinal plants reported by the indigenous communities and local herbal practitioners of Bajaur Agency, Federally Administrated Tribal Areas, Pakistan,” J. Ethnopharmacol., vol. 198, pp. 268–281, 2017, doi: https://doi.org/10.1016/j.jep.2017.01.024.

H. Shaheen, M. F. Qaseem, M. S. Amjad, and P. Bruschi, “Exploration of ethno-medicinal knowledge among rural communities of Pearl Valley; Rawalakot, District Poonch Azad Jammu and Kashmir,” PLoS One, vol. 12, no. 9, p. e0183956, 2017.

I. Süntar, “Importance of ethnopharmacological studies in drug discovery: role of medicinal plants,” Phytochem. Rev., pp. 1–11, 2019.

S. Wang, G. Dong, and C. Sheng, “Structural simplification: an efficient strategy in lead optimization,” Acta Pharm. Sin. B, vol. 9, no. 5, pp. 880–901, 2019, doi: https://doi.org/10.1016/j.apsb.2019.05.004.

S. Krishnaprabu, “Therapeutic potential of medicinal plants: A,” J. Pharmacogn. Phytochem., vol. 9, no. 2, pp. 2228–2233, 2020.

S.-L. C. Haris et al., “Phylogenies reveal predictive power of traditional medicine in bioprospecting,” J Proc. Natl. Acad. Sci., vol. 109, no. 39, pp. 15835–15840, 2012, doi: https://doi.org/10.1073/pnas.1202242109.

J. B. Calixto, “The role of natural products in modern drug discovery.,” An. Acad. Bras. Cienc., vol. 91, 2019.

M. J. D., V. S. K., and H. J. T., “Plant natural products: Back to the future or into extinction,” Phytochemistry, vol. 68, no. 14, pp. 2015–2022, 2007, doi: https://doi.org/10.1016/j.phytochem.2007.04.032.

A. Rasool, K. M. Bhat, A. A. Sheikh, A. Jan, and S. Hassan, “Medicinal plants: Role, distribution and future,” J. Pharmacogn. Phytochem., vol. 9, no. 2, pp. 2111–2114, 2020.

E. J. Buenz, R. Verpoorte, and B. A. Bauer, “The Ethnopharmacologic Contribution to Bioprospecting Natural Products,” Annu. Rev. Pharmacol. Toxicol., vol. 58, no. 1, pp. 509–530, 2018, doi: 10.1146/annurev-pharmtox-010617-052703.

E. Guzman and J. Molina, “The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs,” Pharm. Biol., vol. 56, no. 1, pp. 154–164, 2018, doi: 10.1080/13880209.2018.1444642.

S. Vivekanand and S. I. Neil, “Bioinformatics opportunities for identification and study of medicinal plants,” Brief. Bioinform., vol. 14, no. 2, pp. 238–250, 2012, doi: https://doi.org/10.1093/bib/bbs021.

I. Zahoor, A. Shafi, K. M. Fazili, and E. Haq, “Bioinformatics and Medicinal Plant Research: Current Scenario,” in Essentials of Bioinformatics, Volume III, Springer, 2019, pp. 141–157.

N. Rummun, V. S. Neergheen-Bhujun, K. B. Pynee, C. Baider, and T. Bahorun, “The role of endemic plants in Mauritian traditional medicine – Potential therapeutic benefits or placebo effect?” J. Ethnopharmacol., vol. 213, pp. 111–117, 2018, doi: https://doi.org/10.1016/j.jep.2017.10.006.

C. Beedie et al., “‘Caution, this treatment is a placebo. It might work, but it might not’: why emerging mechanistic evidence for placebo effects does not legitimise complementary and alternative medicines in sport,” Br. J. Sports Med., vol. 52, no. 13, pp. 817 LP – 818, Jul. 2018, doi: 10.1136/bjsports-2017-097747.

S. Singh, D. B. Singh, S. Singh, R. Shukla, P. W. Ramteke, and K. Misra, “Exploring medicinal plant legacy for drug discovery in post-genomic era,” Proc. Natl. Acad. Sci. India Sect. B Biol. Sci., vol. 89, no. 4, pp. 1141–1151, 2019.

H.-G. Morten, E. Madeleine, R. Nina, D. R. R, and S.-L. C. Haris, “Using evolutionary tools to search for novel psychoactive plants,” J Plant Genet. Resour., vol. 14, no. 4, pp. 246–255, 2016, doi: https://doi.org/10.1017/S1479262116000344.

Y. Kowiyou, D. B. H, and M. A. Muthama, “Phylogenetic exploration of commonly used medicinal plants in South Africa,” Mol Ecol Resour, vol. 15, no. 2, pp. 405–413, 2015, doi: https://doi.org/10.1111/1755-0998.12310.

R. Delgoda and J. E. Murray, “Chapter 7 - Evolutionary Perspectives on the Role of Plant Secondary Metabolites,” S. Badal and R. B. T.-P. Delgoda, Eds. Boston: Academic Press, 2017, pp. 93–100.

M. Erb and D. J. Kliebenstein, “Plant secondary metabolites as defenses, regulators, and primary metabolites: the blurred functional trichotomy,” Plant Physiol., vol. 184, no. 1, pp. 39–52, 2020.

Z. Feng et al., “Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting,” Proc. Natl. Acad. Sci. U. S. A., vol. 108, no. 31, pp. 12943–12948, 2011, doi: https://doi.org/10.1073/pnas.1107336108.

A. N. Aid and M. Jeanmaire, “The ethnobotany of psychoactive plant use: a phylogenetic perspective,” PeerJ, vol. 4, pp. e2546–e2546, 2016, doi: https://doi.org/10.7717/peerj.2546.

R. Varo, C. Erice, S. Johnson, Q. Bassat, and K. C. Kain, “Clinical trials to assess adjuvant therapeutics for severe malaria,” Malar. J., vol. 19, no. 1, p. 268, 2020, doi: 10.1186/s12936-020-03340-3.

O. Manel, A. Jean-Michel, P. Lucie, and B.-V. Françoise, “Plasmodium falciparum resistance to artemisinin-based combination therapies: A sword of Damocles in the path toward malaria elimination,” J Parasite, vol. 25, 2018, doi: https://doi.org/10.1051/parasite/2018021.

WHO, World Malaria Report 2019. World Health Organization 2019, 2019.

R. Pasupureddy, S. Seshadri, V. Pande, R. Dixit, and K. C. Pandey, “Current scenario and future strategies to fight artemisinin resistance,” Parasitol. Res., vol. 118, no. 1, pp. 29–42, 2019.

E. A. Ashley and A. P. Phyo, “Drugs in Development for Malaria,” Drugs, vol. 78, no. 9, pp. 861–879, 2018, doi: 10.1007/s40265-018-0911-9.

T. Hanscheid and D. W. Hardisty, “How ‘resistant’ is artemisinin resistant malaria? - The risks of ambiguity using the term ‘resistant’ malaria,” Travel Med. Infect. Dis., vol. 24, pp. 23–24, 2018, doi: https://doi.org/10.1016/j.tmaid.2018.04.008.

J. Wang, C. Xu, F. L. Liao, T. Jiang, S. Krishna, and Y. Tu, “A temporizing solution to ‘artemisinin resistance,’” N. Engl. J. Med., vol. 380, no. 22, pp. 2087–2089, 2019.

T. Chookajorn, “How to combat emerging artemisinin resistance: Lessons from ‘The Three Little Pigs,’” PLoS Pathog., vol. 14, no. 4, p. e1006923, 2018.

K. Yong, D. Zhiyan, Z. Runguo, and L. Wenxing, “DNA barcoding analysis and phylogenetic relationships of tree species in tropical cloud forests,” Sci. Rep., vol. 7, no. 1, pp. 1–9, 2017, doi: https://doi.org/10.1038/s41598-017-13057-0.

T. Gunnels, M. Creswell, J. McFerrin, and J. B. Whittall, “The ITS region provides a reliable DNA barcode for identifying reishi/lingzhi (Ganoderma) from herbal supplements,” PLoS One, vol. 15, no. 11, p. e0236774, 2020.

B. P. Murphy and P. J. Tranel, “Identification and Validation of Amaranthus Species‐Specific SNPs within the ITS Region: Applications in Quantitative Species Identification,” Crop Sci., vol. 58, no. 1, pp. 304–311, 2018.

L. V Ya-Na et al., “Identification of medicinal plants within the Apocynaceae family using ITS2 and psbA-trnH barcodes,” Chin. J. Nat. Med., vol. 18, no. 8, pp. 594–605, 2020.

V. Funk, A. Susanna, T. Stuessy, and R. Bayer, Systematics, Evolution, and Biogeography of Compositae. Veinna, Austria: International Association for Plant Taxonomy, Institue of Botany, University of Vienna, 2009.

N. A. C. Nadia et al., “Antimalarial Activity of Ethyl Acetate Extract and Fraction of Bidens pilosa against Plasmodium berghei (ANKA),” J. Parasitol. Res., vol. 2020, 2020.

R. K. Sahoo et al., “Phytochemical constituents from Xanthium strumarium L. and evaluation of their in vitro antimalarial activities,” South African J. Bot., vol. 135, pp. 35–40, 2020, doi: https://doi.org/10.1016/j.sajb.2020.08.006.

A. A. Ajao and A. N. Moteetee, “Tithonia diversifolia (Hemsl) A. Gray. (Asteraceae: Heliantheae), an invasive plant of significant ethnopharmacological importance: A review,” South African J. Bot., vol. 113, pp. 396–403, 2017, doi: https://doi.org/10.1016/j.sajb.2017.09.017.

I. C. Ezenyi, O. A. Salawu, R. Kulkarni, and M. Emeje, “Antiplasmodial activity-aided isolation and identification of quercetin-4’-methyl ether in Chromolaena odorata leaf fraction with high activity against chloroquine-resistant Plasmodium falciparum,” J Parasitol. Res., vol. 113, no. 12 LB-Ezenyi2014, pp. 4415–4422, 2014, doi: 10.1007/s00436-014-4119-y.

I. H. Ifijen, M. Maliki, O. K. Ogbeide, R. O. Okonkwo, S. O. Omorogbe, and E. U. Ikhuoria, “Chemical Substances and in-Vivo Antiplasmodial Activity of Ageratum Conyzoides in Plasmodium Berghei Infected Mice,” J. Appl. Sci. Environ. Manag., vol. 23, no. 10, pp. 1813–1817, 2019.

F. Koukouikila-Koussounda et al., “In vitro evaluation of antiplasmodial activity of extracts of Acanthospermum hispidum DC (Asteraceae) and Ficus thonningii blume (Moraceae), two plants used in traditional medicine in the Republic of Congo,” African J. Tradit. Complement. Altern. Med., vol. 10, no. 2, pp. 270–276, 2013.

P. Ghosh, S. Biswas, M. Biswas, A. Dutta, S. Sil, and S. Chatterjee, “Morphological, Ethno biological and Phytopharmacological Attributes of Tridax procumbensLinn.(Asteraceae): A Review,” Int. J. Sci. Res. Biol. Sci. Vol, vol. 6, p. 2, 2019.

C. McDonald‐Spicer, N. J. Knerr, F. Encinas‐Viso, and A. N. Schmidt‐Lebuhn, “Big data for a large clade: Bioregionalization and ancestral range estimation in the daisy family (Asteraceae),” J. Biogeogr., vol. 46, no. 2, pp. 255–267, 2019.

J. R. Mandel et al., “The Compositae tree of life in the age of phylogenomics,” J. Syst. Evol., vol. 55, no. 4, pp. 405–410, 2017.

M. E. Gallon, M. Monge, R. Casoti, F. B. Da Costa, J. Semir, and L. Gobbo-Neto, “Metabolomic analysis applied to chemosystematics and evolution of megadiverse Brazilian Vernonieae (Asteraceae),” Phytochemistry, vol. 150, pp. 93–105, 2018.

S. V. Patricia and M. V. Susana, Sesquiterpene Lactones: Advances in Their Chemistry and Biological Aspects. Springer, 2018.

R. Nina et al., “Can phylogeny predict chemical diversity and potential medicinal activity of plants? A case study of Amaryllidaceae,” BMC Evol. Biol., vol. 12, no. 1, p. 182, 2012, doi: https://doi.org/10.1186/1471-2148-12-182.

A. SAV, F. MJP, E. VP, and C.-B. D, “Chemosystematic studies of natural compounds isolated from Asteraceae: characterization of tribes by principal component analysis,” Chemom. Intell. Lab. Syst., vol. 56, no. 1, pp. 27–37, 2001, doi: https://doi.org/10.1016/S0169-7439(01)00103-4.

S. S., The Chemistry of Natural Products: 6: Plenary Lectures Presented at the Sixth International Symposium on the Chemistry of Natural Products. Elsevier Science, 2013.

Z. Christian, “Sesquiterpene lactones and their precursors as chemosystematic markers in the tribe Cichorieae of the Asteraceae,” Phytochemistry, vol. 69, no. 12, pp. 2270–2296, 2008, doi: https://doi.org/10.1016/j.phytochem.2008.06.013.

K. E., Z. L., and R. A., “Secondary metabolites of some Siberian species of plants tribe Cynareae (Asteraceae),” South African J. Bot., vol. 125, pp. 24–29, 2019, doi: https://doi.org/10.1016/j.sajb.2019.06.022.

C. Lalita, E. Vicente, F. Marcelo, S. Marcus, and M. Tom, “A Phylogenetic Analysis of Tribes of the Asteraceae Based on Phytochemical Data,” Nat. Prod. Commun., vol. 2, pp. 277–285, 2007.

A. M. Feitosa, S. Luciana, D. C. F. Batista, and S. M. Tullius, “Chemotaxonomic Study of Sesquiterpene Lactones of Asteraceae: Classical and Modern Methods,” in Sesquiterpene Lactones: Advances in their Chemistry and Biological Aspects, V. P. Sülsen and V. S. Martino, Eds. Cham: Springer International Publishing, 2018, pp. 31–45.

S. F. C., “Sesquiterpene lactones as taxonomic characters in the asteraceae,” Bot. Rev., vol. 48, no. 2, pp. 121–594, 1982, doi: http://dx.doi.org/10.1007/BF02919191.

B. Joshi, S. Hendrickx, L. B. Magar, N. Parajuli, P. Dorny, and L. Maes, “In vitro antileishmanial and antimalarial activity of selected plants of Nepal,” J Intercult Ethnopharmacol, vol. 5, no. 4, pp. 383–389, 2016, doi: 10.5455/jice.20160728031236.

M. Laila, C. Oliver, S. Pedro, S. Farukh, and S. A. ML, “Applications of Sesquiterpene Lactones: A Review of Some Potential Success Cases,” J Appl. Sci., vol. 10, no. 9, p. 3001, 2020, doi: http://10.3390/app10093001.

S. K. Mandal et al., “Natural Sesquiterpene Lactones in the Prevention and Treatment of Inflammatory Disorders and cancer: A Systematic Study of this Emerging Therapeutic Approach based on Chemical and Pharmacological Aspect,” Lett. Drug Des. Discov., vol. 17, no. 9, pp. 1102–1116, 2020.

T. J. Schmidt, “Structure-Activity and Activity-Activity Relationships of Sesquiterpene Lactones BT - Sesquiterpene Lactones: Advances in their Chemistry and Biological Aspects,” V. P. Sülsen and V. S. Martino, Eds. Cham: Springer International Publishing, 2018, pp. 349–371.

O. P. M., B. V. E., and W. S. A., “The molecular mechanism of action of artemisinin--the debate continues,” Molecules, vol. 15, no. 3, pp. 1705–1721, 2010, doi: http://10.3390/molecules15031705.

S. Gunjan et al., “Artemisinin derivatives and synthetic trioxane trigger apoptotic cell death in asexual stages of plasmodium,” Front. Cell. Infect. Microbiol., vol. 8, p. 256, 2018.




DOI: http://dx.doi.org/10.18517/ijaseit.11.2.12973

Refbacks

  • There are currently no refbacks.



Published by INSIGHT - Indonesian Society for Knowledge and Human Development